IGG HEAVY CHAIN (SURFACE)

 This test is used to detect the expression of the IgG heavy chain on the surface of B cells, which can be important in diagnosing and classifying B-cell lymphoproliferative disorders such as multiple myeloma or chronic lymphocytic leukemia. It helps identify clonal B-cell populations that may be indicative of malignancy.

 Detecting surface IgG expression helps determine whether a group of B cells is monoclonal, a hallmark of many hematological malignancies. It assists in differentiating between reactive and neoplastic lymphoid proliferations and can guide further molecular or cytogenetic testing.

The test typically uses a blood or bone marrow sample. Flow cytometry is the method used to identify B cells expressing surface IgG. The sample is analyzed using fluorescent-tagged antibodies that bind specifically to surface immunoglobulin molecules.

A monoclonal population of IgG-expressing B cells suggests a possible underlying malignancy. In contrast, polyclonal expression usually indicates a reactive, non-cancerous process. Your doctor may recommend further testing based on the results.

 Further testing may include immunophenotyping, bone marrow biopsy, or genetic studies. Treatment depends on the final diagnosis and may range from observation to chemotherapy or immunotherapy in confirmed cases of lymphoid malignancy.